Family-centered Tai Chi exercise for lung function and mental health after lung surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study explores the effects of an eight-week family-centered Tai Chi exercise program on lung function and mental health in patients recovering from thoracoscopic surgery for lung cancer. The research aims to address the decline in lung function and the psychological burden experienced by patients and their caregivers post-surgery. Participants will be divided into an experimental group, which will engage in Tai Chi exercises, and a control group receiving standard treatment. The study will utilize a quasi-experimental design with repeated measures analysis to evaluate outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Hospitalized to receive thoracoscopic lobectomy, wedge/partial resection, lobectomy, or sleeve resection.
2. American Society of Anesthesiologists (ASA) physiological status classification I-II (ASA, 2019).ASA Physical Status Class I: A healthy person who is healthy and does not smoke or drink.ASA physical status class II: People with mild chronic diseases but no substantial functional limitations.
3. Those who can walk on their own without any impairment in limb movement.
4. Able to communicate in Chinese or Taiwanese.

Exclusion Criteria:

1. Individuals requiring chemotherapy and radiation therapy for malignant tumors.
2. Those who have practiced Tai Chi, Qigong, external elixir exercises, or pulmonary exercises within the past year.
3. Anticipating hospitalization or surgical treatment within the next three months.
4. Individuals with musculoskeletal or peripheral vascular diseases.
5. Individuals with visual impairment, intellectual disabilities, or memory loss.

Where it's running

• China Medical University
  Taichung, North Dist., Taiwan Recruiting

Study contacts

• Principal investigator: Hsing-Chi Hsu, Ph.D — HungKuang University, Taiwan
• Study coordinator: Hsin-Yuan Fang, Ph.D
• Email: fanghy@cmuh.org.tw
• Phone: 04-22052121

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Heart-friendly medicines to protect chest-area cancer patients from radiation damage

  This Phase 2 trial tests whether taking atorvastatin and lisinopril can reduce heart damage in adults with chest-area cancers who receive radiation therapy.

  Recruiting Phase 2 UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT07685938

• Kyphoplasty combined with radiofrequency ablation and radiation for painful thoracic and lumbar spine tumors

  This treatment plan tries to reduce moderate-to-severe back pain in adults whose cancer has spread to the thoracic or lumbar spine by combining kyphoplasty, radiofrequency ablation (OsteoCool), and external beam radiation.

  Recruiting UNC Lineberger Comprehensive Cancer Center · Chapel Hill, North Carolina · NCT07479199

• Tarlatamab as maintenance treatment after chemo-radiotherapy for limited-stage small-cell lung cancer.

  This trial will test whether giving tarlatamab after chemo-radiotherapy helps people with limited-stage small-cell lung cancer stay progression-free longer.

  Recruiting at 20 sites Phase 2 Fundación GECP · Albacete, Albacete and 19 other locations · NCT07242547

• Thiopegfilgrastim to prevent bone marrow suppression during chemoradiotherapy for esophageal or lung cancer

  This will try mecapegfilgrastim (a long-acting G-CSF) to prevent low neutrophil counts in adults with esophageal or lung cancer receiving concurrent chemoradiotherapy.

  Recruiting Phase 2 Affiliated Hospital of Nantong University · Nantong, Jiangsu · NCT07205536

• Early intervention strategies for lung cancer detection

  This study is testing if using low-dose CT scans in community health centers can help find lung cancer earlier in people aged 40-75 who don't have a history of the disease.

  Recruiting The First Affiliated Hospital of Guangzhou Medical University · Guangzhou, Guangdong · NCT06988943

• Cemiplimab guided by ctDNA levels (PALACE)

  This study will see if starting adults with advanced (stage IIIB/C or IV) non-small cell lung cancer and PD-L1 ≥50% on cemiplimab, then using ctDNA and early scans to decide whether to add chemotherapy, can improve overall survival.

  Recruiting at 19 sites Phase 2 Fundación GECP · Alicante, Alicante and 19 other locations · NCT06917573

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.